Journal of Cachexia, Sarcopenia and Muscle
Denosumab linked to greater grip strength gains in women
At 12 months, grip strength rose 1.45 kg with denosumab versus 0.66 kg with zoledronic acid in postmenopausal women with osteoporosis.At 12 months, grip strength rose 1.45 kg with denosumab versus 0.66 kg with zoledronic acid in postmenopausal women with osteoporosis.
Cohort · 186 peopleDenosumab
Who was studied186 postmenopausal women with osteoporosis and prescreened sarcopenia risk, 36 months
What changedGrip strength increased 1.53 kg more with denosumab than zoledronic acid over 36 months
The catchUnmeasured comorbidities could partly explain the grip-strength difference
